BCYC logo

Bicycle Therapeutics plc (BCYC) EBITDA

Annual EBITDA:

-$245.29M-$36.22M(-17.32%)
December 31, 2024

Summary

  • As of today, BCYC annual EBITDA is -$245.29 million, with the most recent change of -$36.22 million (-17.32%) on December 31, 2024.
  • During the last 3 years, BCYC annual EBITDA has fallen by -$178.45 million (-266.96%).
  • BCYC annual EBITDA is now -1754.86% below its all-time high of -$13.22 million, reached on December 1, 2016.

Performance

BCYC EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBCYCincome statement metrics

Quarterly EBITDA:

-$71.14M+$27.19M(+27.65%)
September 30, 2025

Summary

  • As of today, BCYC quarterly EBITDA is -$71.14 million, with the most recent change of +$27.19 million (+27.65%) on September 30, 2025.
  • Over the past year, BCYC quarterly EBITDA has dropped by -$526.30 thousand (-0.75%).
  • BCYC quarterly EBITDA is now -2495.22% below its all-time high of -$2.74 million, reached on March 31, 2018.

Performance

BCYC Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBCYCincome statement metrics

TTM EBITDA:

-$324.13M-$526.30K(-0.16%)
September 30, 2025

Summary

  • As of today, BCYC TTM EBITDA is -$324.13 million, with the most recent change of -$526.30 thousand (-0.16%) on September 30, 2025.
  • Over the past year, BCYC TTM EBITDA has dropped by -$96.31 million (-42.27%).
  • BCYC TTM EBITDA is now -5383.86% below its all-time high of -$5.91 million, reached on December 1, 2017.

Performance

BCYC TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBCYCincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

BCYC EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-17.3%-0.8%-42.3%
3Y3 Years-267.0%-104.2%-194.8%
5Y5 Years-875.6%-617.1%-780.3%

BCYC EBITDA Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-267.0%at low-104.2%+27.6%-194.8%at low
5Y5-Year-875.6%at low-617.1%+27.6%-780.3%at low
All-TimeAll-Time-1754.9%at low-2495.2%+27.6%-5383.9%at low

BCYC EBITDA History

DateAnnualQuarterlyTTM
Sep 2025
-
-$71.14M(+27.7%)
-$324.13M(-0.2%)
Jun 2025
-
-$98.33M(-26.1%)
-$323.60M(-16.5%)
Mar 2025
-
-$77.98M(-1.7%)
-$277.75M(-13.3%)
Dec 2024
-$245.29M(-17.3%)
-$76.68M(-8.6%)
-$245.22M(-7.6%)
Sep 2024
-
-$70.61M(-34.6%)
-$227.82M(-8.2%)
Jun 2024
-
-$52.48M(-15.5%)
-$210.55M(-2.2%)
Mar 2024
-
-$45.45M(+23.3%)
-$206.10M(+0.9%)
Dec 2023
-$209.07M(-55.3%)
-$59.28M(-11.1%)
-$208.04M(-11.1%)
Sep 2023
-
-$53.34M(-11.1%)
-$187.29M(-11.0%)
Jun 2023
-
-$48.03M(-1.4%)
-$168.79M(-11.5%)
Mar 2023
-
-$47.39M(-23.0%)
-$151.36M(-15.5%)
Dec 2022
-$134.64M(-101.4%)
-$38.52M(-10.5%)
-$131.07M(-19.2%)
Sep 2022
-
-$34.85M(-13.9%)
-$109.94M(-22.3%)
Jun 2022
-
-$30.60M(-13.0%)
-$89.87M(-16.8%)
Mar 2022
-
-$27.09M(-55.7%)
-$76.97M(-17.3%)
Dec 2021
-$66.84M
-$17.40M(-17.7%)
-$65.63M(-0.4%)
Sep 2021
-
-$14.78M(+16.5%)
-$65.38M(-8.0%)
DateAnnualQuarterlyTTM
Jun 2021
-
-$17.70M(-12.3%)
-$60.52M(-10.0%)
Mar 2021
-
-$15.75M(+8.1%)
-$55.02M(-11.6%)
Dec 2020
-$52.36M(-108.3%)
-$17.15M(-72.8%)
-$49.31M(-33.9%)
Sep 2020
-
-$9.92M(+18.7%)
-$36.82M(-2.1%)
Jun 2020
-
-$12.20M(-21.5%)
-$36.05M(-11.7%)
Mar 2020
-
-$10.04M(-115.9%)
-$32.27M(-27.4%)
Dec 2019
-$25.14M(-18.1%)
-$4.65M(+49.2%)
-$25.33M(+10.5%)
Sep 2019
-
-$9.15M(-8.7%)
-$28.31M(-11.5%)
Jun 2019
-
-$8.42M(-170.3%)
-$25.39M(-15.0%)
Mar 2019
-
-$3.11M(+59.2%)
-$22.08M(-1.7%)
Dec 2018
-$21.30M(-37.9%)
-$7.63M(-22.4%)
-$21.71M(-8.6%)
Sep 2018
-
-$6.23M(-22.1%)
-$19.99M(-45.3%)
Jun 2018
-
-$5.11M(-86.2%)
-$13.76M(-59.0%)
Mar 2018
-
-$2.74M(+53.6%)
-$8.65M(-46.4%)
Dec 2017
-$15.44M(-16.8%)
-
-
Dec 2017
-
-$5.91M
-$5.91M
Dec 2016
-$13.22M
-
-

FAQ

  • What is Bicycle Therapeutics plc annual EBITDA?
  • What is the all-time high annual EBITDA for Bicycle Therapeutics plc?
  • What is Bicycle Therapeutics plc annual EBITDA year-on-year change?
  • What is Bicycle Therapeutics plc quarterly EBITDA?
  • What is the all-time high quarterly EBITDA for Bicycle Therapeutics plc?
  • What is Bicycle Therapeutics plc quarterly EBITDA year-on-year change?
  • What is Bicycle Therapeutics plc TTM EBITDA?
  • What is the all-time high TTM EBITDA for Bicycle Therapeutics plc?
  • What is Bicycle Therapeutics plc TTM EBITDA year-on-year change?

What is Bicycle Therapeutics plc annual EBITDA?

The current annual EBITDA of BCYC is -$245.29M

What is the all-time high annual EBITDA for Bicycle Therapeutics plc?

Bicycle Therapeutics plc all-time high annual EBITDA is -$13.22M

What is Bicycle Therapeutics plc annual EBITDA year-on-year change?

Over the past year, BCYC annual EBITDA has changed by -$36.22M (-17.32%)

What is Bicycle Therapeutics plc quarterly EBITDA?

The current quarterly EBITDA of BCYC is -$71.14M

What is the all-time high quarterly EBITDA for Bicycle Therapeutics plc?

Bicycle Therapeutics plc all-time high quarterly EBITDA is -$2.74M

What is Bicycle Therapeutics plc quarterly EBITDA year-on-year change?

Over the past year, BCYC quarterly EBITDA has changed by -$526.30K (-0.75%)

What is Bicycle Therapeutics plc TTM EBITDA?

The current TTM EBITDA of BCYC is -$324.13M

What is the all-time high TTM EBITDA for Bicycle Therapeutics plc?

Bicycle Therapeutics plc all-time high TTM EBITDA is -$5.91M

What is Bicycle Therapeutics plc TTM EBITDA year-on-year change?

Over the past year, BCYC TTM EBITDA has changed by -$96.31M (-42.27%)
On this page